Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors

Bioorg Med Chem. 2010 Sep 15;18(18):6708-14. doi: 10.1016/j.bmc.2010.07.062. Epub 2010 Aug 1.

Abstract

Two new series of biphenyls, analogs of aglycone of natural product fortuneanoside E, were prepared using Suzuki-Miyaura cross-coupling and selective magnesium iodide demethylation/debenzylation, and their mushroom tyrosinase inhibitory activity was evaluated. Most of the 4-hydroxy-3,5-dimethoxyphenyl biphenyl compounds (series II, 20-36) were in general more active than 3,4,5-trimethoxyphenyl biphenyl compounds (series I, 1-19). Structure-activity relationships study showed that monosaccharide substituents, such as glucose, were not necessary and the presence of 4-hydroxy-3,5-dimethoxyphenyl moiety was crucial for inhibitory activity. Among the compounds synthesised, compound 21 (IC50=0.02 mM) was found to be the most active one, which exhibited an activity that was 7 times higher than that of fortuneanoside E (IC50=0.14 mM) and 10 times higher than that of arbutin (IC50=0.21 mM), known as potent tyrosinase inhibitors. The inhibition kinetics analyzed by Lineweaver-Burk plots revealed that compound 21 was a competitive inhibitor (Ki=0.015 mM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agaricales / enzymology*
  • Biphenyl Compounds / chemical synthesis*
  • Biphenyl Compounds / chemistry*
  • Biphenyl Compounds / pharmacology
  • Drug Design
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Kinetics
  • Monophenol Monooxygenase / antagonists & inhibitors*
  • Monophenol Monooxygenase / metabolism
  • Salicylates / chemical synthesis*
  • Salicylates / chemistry
  • Salicylates / pharmacology
  • Structure-Activity Relationship

Substances

  • 3,4'-dihydroxy-3',5'-dimethoxybiphenyl-4-carboxylic acid
  • Biphenyl Compounds
  • Enzyme Inhibitors
  • Salicylates
  • diphenyl
  • Monophenol Monooxygenase